Abrogation of the hematological activities of the GM-CSF/IL-3 fusion protein (PIXY321) by anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin: Results of a phase I study.

被引:0
|
作者
Miller, LL
Korn, EL
Stevens, DS
Janik, JE
Gause, BL
Kopp, WC
Longo, DL
机构
[1] NCI,BRMP,FREDERICK,MD 21701
[2] NCI,CTEP,BETHESDA,MD 20892
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2012 / 2012
页数:1
相关论文
共 20 条
  • [1] Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin
    Miller, LL
    Korn, EL
    Stevens, DS
    Janik, JE
    Gause, BL
    Kopp, WC
    Holmlund, JT
    Curti, BD
    Sznol, M
    Smith, JW
    Urba, WJ
    Donegan, SE
    Watson, TM
    Longo, DL
    BLOOD, 1999, 93 (10) : 3250 - 3258
  • [2] PIXY321 (GM-CSF IL-3 FUSION PROTEIN) - BIOLOGY AND EARLY CLINICAL DEVELOPMENT
    VADHANRAJ, S
    STEM CELLS, 1994, 12 (03) : 253 - 261
  • [3] THE EFFECTS OF PIXY321 (GM-CSF/IL-3 FUSION PROTEIN) TREATMENT ON HUMAN GRANULOCYTE FUNCTION
    BUESCHER, ES
    MCILHERAN, SM
    BANKS, SM
    VADHANRAJ, S
    CLINICAL RESEARCH, 1993, 41 (02): : A363 - A363
  • [4] Effects of PIXY321 (GM-CSF/IL-3 fusion protein) in patients (PTS) with myelodysplastic syndromes (MDS)
    VadhanRaj, S
    Broxmeyer, HE
    Jeha, S
    Estey, E
    Andreeff, M
    Thompson, P
    TrahanRieger, P
    Garrison, L
    BLOOD, 1995, 86 (10) : 1336 - 1336
  • [5] Effects of PIXY321 (GM-CSF/IL-3 fusion protein) in pediatric patients (PTS) with bone marrow failure
    Jeha, S
    Hoots, WK
    Garrison, L
    VadhanRaj, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1032 - 1032
  • [6] THE EFFECTS OF TREATMENT WITH PIXY321 (GM-CSF/IL-3 FUSION PROTEIN) ON HUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTION
    BUESCHER, ES
    MCILHERAN, SM
    BANKS, SM
    VADHANRAJ, S
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (11) : 1467 - 1472
  • [7] STIMULATION OF HEMATOPOIESIS BY PIXY321 (GM-CSF/IL-3 FUSION PROTEIN) IN PATIENTS WITH BONE-MARROW FAILURE
    VADHANRAJ, S
    JEHA, S
    BROXMEYER, HE
    HITTELMAN, WN
    THOMPSON, P
    ARCENAS, A
    HOOTS, WK
    ESTEY, E
    GARRISON, L
    BLOOD, 1993, 82 (10) : A366 - A366
  • [8] The effect of the GM-CSF/IL-3 fusion protein PIXY321 on bone marrow and circulating haemopoietic cells of previously untreated patients with cancer
    Ghielmini, M
    Pettengell, R
    Coutinho, LH
    Testa, N
    Crowther, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (01) : 6 - 12
  • [9] INVIVO EFFECTS OF A GM-CSF/IL-3 FUSION PROTEIN (PIXY 321) IN SUBLETHALLY IRRADIATED MONKEYS
    WILLIAMS, DE
    FARESE, A
    DUNN, J
    FRIEDEN, E
    PARK, LS
    MACVITTIE, TJ
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 584 - 584
  • [10] HEMATOLOGIC EFFECTS OF INVIVO ADMINISTRATION OF RECOMBINANT GM-CSF IL-3 FUSION PROTEIN (PIXY-321) IN NORMAL PRIMATES
    MACVITTIE, TJ
    FARESE, AM
    PATCHEN, ML
    WILLIAMS, DE
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 503 - 503